Prevalence of multiple sclerosis in the city of Volta Redonda – Rio de Janeiro, Brazil- using the capture-recapture method

Calmon, Ana Beatriz; Pereira, Fernanda; Preux, Pierre‐Marie; Marin, Benoît; Alvarenga, Regina

doi:10.1016/j.jns.2015.08.1060

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Six moderate-quality studies were included in this metaanalysis [106][107][108][109][110][111]. All studies reported a very low MS prevalence and proportion of SPMS patients.…”

Section: Brazilmentioning

confidence: 99%

See 1 more Smart Citation

Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil

Vasanthaprasad

Khurana²,

Vadapalle

et al. 2022

BMC Neurol

View full text Add to dashboard Cite

Background Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS), which is a chronic neurological disease, characterised by inflammation of the central nervous system. Most of MS patients eventually progress to SPMS. This study estimates the prevalence of SPMS in the United States of America, Europe, Canada, Australia, and Brazil. Methods A systematic literature search of the Medline and Embase databases was performed using the OVID™ SP platform to identify MS epidemiological studies published in English from database inception to September 22, 2020. Studies reporting the prevalence of MS and proportion of SPMS patients in the included population were selected. The pooled prevalence of SPMS was calculated based on the proportion of SPMS patients. The Loney quality assessment checklist was used for quality grading. A meta-analysis of the proportions was conducted in RStudio. Results A total of 4754 articles were retrieved, and prevalence was calculated from 97 relevant studies. Overall, 86 medium- and high-quality studies were included in the meta-analysis. Most studies were conducted in European countries (84 studies). The estimated pooled prevalence of SPMS was 22.42 (99% confidence interval: 18.30, 26.95)/100,000. The prevalence of SPMS was more in the North European countries, highest in Sweden and lowest in Brazil. A decline in SPMS prevalence was observed since the availability of oral disease-modifying therapies. We also observed a regional variation of higher SPMS prevalence in urban areas compared with rural areas. Conclusion High variability was observed in the estimated SPMS prevalence, and the quality of the studies conducted. The influence of latitude and other factors known to affect overall MS prevalence did not fully explain the wide range of inter-country and intra-country variability identified in the results.

show abstract

“…Six moderate-quality studies were included in this metaanalysis [106][107][108][109][110][111]. All studies reported a very low MS prevalence and proportion of SPMS patients.…”

Section: Brazilmentioning

confidence: 99%

“…All studies reported a very low MS prevalence and proportion of SPMS patients. The pooled prevalence of SPMS was 1.68 (99% CI: 0.53, 3.31)/100,000 [106][107][108][109][110][111] (Table 1 and Fig. 2).…”

Section: Brazilmentioning

confidence: 99%